The Current State of Prostate Cancer Management in Guyana, 2024

Abstract

Objective: To assess the current burden of Prostate Cancer in Guyana and review its treatment modalities. Design and Methods: Data was collected using the key performance indicator report from the men’s health report with approval. It showed an increase interest for PSA screening over the months of 2024 as the “Guidelines for the Management of Prostate Health” were rolled out; resulting of 13, 688 test. 2600 were elevated and 536 biopsies were done. Clinicopathological data showed 96% acinar carcinoma and 4% ductal cell carcinoma. However, oncological care is limited in brachytherapy and external beam radiation. Palliative care is limited in the public sector for prostate cancer patients. Conclusion: Men is Guyana has welcomed the PSA as a screening tool but clinicopathological data showed higher rate of ductal in ductal cell carcinoma than international data. However, more oncological care for prostate cancer needs to implement to aid modern interventions to that of our regional countries.